Prognostic Value of the Eosinophil-to-Neutrophil Ratio for In-Hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Authors: Hong-Joon Shin, Sung-Chul Lim Published: 2026 ABSTRACT Inflammatory biomarkers reflecting acute immune responses may aid prognostic stratification in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (COPD). The eosinophil–neutrophil ratio (ENR) integrates two key inflammatory cell populations; however, its prognostic value in the acute exacerbation of COPD has not been fully established. We conducted a retrospective cohort study of patients hospitalized for acute exacerbation of COPD between 2016 and 2021. ENR was calculated using peripheral blood eosinophil and neutrophil counts obtained at hospital admission. Patients were categorized into quartiles based on ENR, and outcomes were compared between the lowest quartile (Q1) and the upper three quartiles (Q2-Q4). The primary outcome was in-hospital mortality, and secondary outcomes included all-cause mortality within one year. A total of 435 patients were included (Q1, n=109; Q2-Q4, n=326). The cohort was predominantly male, with a mean age of 74 years. Mean ENR values were significantly lower in Q1 than in Q2-Q4 (0.0002 vs. 0.0471, p<0.001). In-hospital mortality was significantly higher in the Q1 group compared with the Q2-Q4 group (5.5% vs. 1.2%, p=0.019). In multivariable logistic regression analyses, low ENR remained independently associated with an increased in-hospital (adjusted odds ratio, 9.05; 95% confidence interval, 2.19-37.39; p=0.002). ENR was not associated with long-term survival. A low ENR at hospital admission is an independent predictor of in-hospital mortality in patients hospitalized with acute exacerbation of COPD, reflecting heightened acute-phase disease severity. INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide and is characterized by persistent respiratory symptoms, airflow limitation, and recurrent acute exacerbations.1 Acute exacerbations of COPD accelerate lung function decline, impair health-related quality of life, and are strongly associated with hospitalization and death.234 Early identification of patients at high risk of short-term adverse outcomes during acute exacerbation of COPD is therefore essential for optimizing in-hospital management. Airway and systemic inflammation in COPD are heterogeneous and involve distinct inflammatory cell profiles that may have different prognostic and therapeutic implications. Eosinophilic inflammation, which is present in a substantial subset of patients with COPD, has been linked to type 2 inflammatory pathways and has a favorable response to inhaled corticosteroids and thus has been proposed as a treatable trait in COPD.56 In contrast, neutrophil-dominant inflammation is considered a hallmark of COPD pathogenesis; activated neutrophils contribute to tissue destruction, mucus hypersecretion, and increased susceptibility to infection, and elevated blood neutrophil counts have been associated with a higher risk of exacerbations and mortality.789 These observations suggest that simple blood-based indices reflecting the balance between eosinophilic and neutrophilic inflammation may provide clinically meaningful information in the setting of acute exacerbation of COPD. The eosinophil–neutrophil ratio (ENR), derived from a routine complete blood count, represents an easily obtainable composite marker integrating both eosinophilic and neutrophilic responses. Previous studies in critically ill patients with acute exacerbation of COPD have suggested that lower ENR values—often reflecting eosinopenia accompanied by marked neutrophilia—are associated with increased in-hospital mortality, supporting the concept that an eosinopenic–neutrophilic inflammatory pattern represents a particularly severe exacerbation phenotype.4610 However, evidence regarding the prognostic value of ENR at hospital admission in patients hospitalized with acute exacerbation of COPD remains limited, and its association with both short- and long-term outcomes has not been fully elucidated. Therefore, the present study aimed to investigate the prognostic significance of admission ENR in patients hospitalized with acute exacerbation of COPD. MATERIALS AND METHODS 1. Study design and population This retrospective study analyzed the medical records of patients with COPD who were hospitalized at one tertiary referral center and one secondary care hospital between January 2016 and August 2021. COPD was diagnosed in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, defined by a post-bronchodilator forced expiratory volume in one second to a forced vital capacity ratio of less than 70% of the predicted value.1 Acute exacerbation of COPD was also defined based on GOLD recommendations, characterized by an acute deterioration of respiratory symptoms requiring additional therapeutic intervention.1 Patients were excluded if recent pulmonary function test results were unavailable or if the admission was associated with conditions such as pneumothorax, pleural effusion, pulmonary embolism, pulmonary edema, or cardiac arrhythmia. This study was approved by the Institutional Review Board of Chonnam National University Hospital (approval no. CNUH-2024-011). The study was conducted in accordance with the principles of the Declaration of Helsinki and applicable regulatory requirements. Given the retrospective nature of the study and the minimal risk to participants, the Institutional Review Board waived the requirement for informed consent. All patient information was anonymized and de-identified prior to data analysis. 2. Data collection Clinical and demographic information was extracted from electronic medical records, including age, sex, body mass index, smoking status, and comorbid conditions such as hypertension, diabetes mellitus, pulmonary tuberculosis, bronchiectasis, ischemic heart disease, and chronic kidney disease. Pulmonary function test results were collected when available. Initial laboratory parameters included white blood cell count, neutrophil count and percentage, eosinophil count and percentage, and levels of hemoglobin, platelets, blood urea nitrogen, creatinine, and C-reactive protein. Disease severity was assessed using the GOLD airflow limitation stage.1 Information regarding prior maintenance therapy and in-hospital management—including conventional oxygen therapy, high-flow nasal cannula, non-invasive ventilation, intensive care unit admission, endotracheal intubation, and the use of antibiotics and systemic corticosteroids—was also obtained. Clinical outcomes evaluated in this study included in-hospital mortality and all-cause mortality within one year. 3. Definition of the ENR ENR was calculated by dividing the absolute eosinophil count by the absolute neutrophil count obtained from the complete blood count at the time of hospital admission. ENR was analyzed both as a continuous variable and as a categorical variable based on quartiles. Patients in the lowest quartile (Q1) were classified as having low ENR, whereas those in the upper three quartiles (Q2-4) served as the reference group. Because ENR values were small in absolute magnitude, results are presented to four decimal places. 4. Statistical analysis Continuous variables are presented as mean (standard deviation), and categorical variables are expressed as number (percentage). Comparisons between groups according to ENR quartiles (Q1 vs. Q2-4) were performed using the Student’s t-test for continuous variables and the chi-square test or Fisher’s exact test for categorical variables, as appropriate. The association between ENR and in-hospital mortality was evaluated using logistic regression analyses. ENR was analyzed both as a continuous variable and as a categorical variable based on quartiles. Multivariable models were constructed with stepwise adjustment for potential confounders, including age and sex (Model 1), and additional adjustment for lung function and systemic inflammation (Model 2). Odds ratios (ORs) with 95% confidence intervals (CIs) are reported. The discriminatory performance of ENR for predicting in-hospital mortality was assessed using receiver operating characteristic curve analysis, and the area under the curve was calculated. An optimal cut-off value for ENR was determined using the Youden index. Kaplan–Meier survival curves were generated to compare 12-month survival between groups, and differences were assessed using the log-rank test. All statistical analyses were performed using R software (R Foundation for Statistical Computing, Vienna, Austria) and SPSS version 25.0 (IBM, Armonk, NY, USA). A two-sided p-value<0.05 was considered statistically significant. RESULTS During the study period, 871 hospitalized patients with a diagnosis of COPD were initially screened (Fig. 1). Following the exclusion of admissions unrelated to acute exacerbation, cases lacking pulmonary function test results, and patients with concomitant bronchial asthma, 435 patients with acute exacerbation of COPD were included in the final cohort. Patients were subsequently categorized according to quartiles of the ENR, with 109 patients classified into the lowest quartile (Q1) and 326 patients into the upper three quartiles (Q2-4). 1. Baseline characteristics of patients hospitalized with acute exacerbation of COPD according to ENR quartiles Baseline characteristics according to ENR quartiles are summarized in Table 1. The mean age was similar between the Q1 and Q2-4 groups (74.14 vs. 74.50), and no significant difference was observed in the proportion of male patients (87.2% vs. 84.0%). Patients in the Q1 group were comparable to those in the Q2-4 group in terms of age, sex distribution, body mass index, and most comorbidities. However, patients in the Q1 group had a higher smoking burden, with a greater proportion of current smokers and higher pack-year exposure. With respect to pulmonary function, patients in the Q1 group demonstrated significantly worse lung function, including lower FEV1 (L), FEV1 (% predicted), and DLco, compared with those in the Q2-4 group. In addition, the distribution of GOLD airflow limitation stages differed significantly between the groups, with more advanced stages observed in the Q1 group. 2. Clinical variables of patients with acute exacerbation of COPD based on ENR quartiles Laboratory findings differed markedly between the two groups (Table 2). Patients in the Q1 group had significantly higher white blood cell counts, neutrophil counts, and neutrophil proportions, along with markedly lower eosinophil counts and percentages, compared with those in the Q2-4 group (all p<0.001). Accordingly, the ENR values were substantially lower in the Q1 group (0.0002 vs. 0.0471; p<0.001). Blood urea nitrogen and C-reactive protein levels were significantly higher in patients in the Q1 group. In contrast, there were no significant differences between the two groups in intensive care unit admission, intubation, or length of hospital stay. In-hospital mortality was significantly higher in the Q1 group than in the Q2-4 (5.5% vs. 1.2%; p=0.019). 3. Prognostic value of the eosinophil–neutrophil ratio for in-hospital mortality The prognostic value of ENR for in-hospital mortality was further evaluated using logistic regression analyses (Table 3). When analyzed as a continuous variable, higher ENR values were significantly associated with a lower risk of in-hospital mortality in the crude model, and this association remained robust after adjustment for age and sex, as well as additional adjustment for lung function and systemic inflammation. Receiver operating characteristic curve analysis demonstrated that ENR had good discriminative ability for predicting in-hospital mortality (Fig. 2). The area under the curve was 0.797 (95% CI, 0.712–0.882; p=0.001). Using the Youden index, the optimal ENR cut-off value was 0.0025, yielding a sensitivity of 0.90 and a specificity of 0.67. Consistent findings were observed when ENR was analyzed categorically. Patients in the Q1 group had a significantly higher risk of in-hospital mortality compared with those in the Q2-4 group (Table 3). This association persisted after multivariable adjustment and was further strengthened in the fully adjusted model. 4. Long-term survival based on ENR quartiles Kaplan–Meier survival analysis showed no significant difference in 12-month survival between patients in the Q1 and those in the Q2-4 group (log-rank p=0.901) (Fig. 3). DISCUSSION In this retrospective study, a lower ENR at hospital admission was independently associated with increased in-hospital mortality in patients with acute exacerbation of COPD. This association was consistent across both continuous and categorical analyses and remained significant after adjustment for key clinical factors. Patients in the lowest ENR quartile exhibited a neutrophil-dominant inflammatory profile and had a higher risk of in-hospital death compared with those in the upper quartiles. In contrast, ENR was not associated with long-term survival, suggesting that it reflects acute disease severity during exacerbation. The biological plausibility of our results is supported by current understanding of eosinophilic and neutrophilic inflammation in COPD. Higher blood eosinophil counts have been consistently associated with a greater reduction in exacerbations in response to inhaled corticosteroids and, in some cohorts, with better overall survival.911 Thus, relative eosinophilia in COPD may represent a treatable trait characterized by steroid-responsive inflammation and a more favorable prognosis.912 Thus, in contrast, neutrophilic inflammation is central to COPD pathogenesis.13 Large observational cohorts have shown that higher blood neutrophil counts are strongly and independently associated with an increased frequency of exacerbations, hospitalizations and mortality in stable COPD, regardless of disease stage.14 During exacerbations, elevated neutrophil to lymphocyte ratio or neutrophil counts have been linked to a markedly higher risk of in-hospital and short-term mortality, with risk rising steeply above specific thresholds.1516 The combination of neutrophilia and eosinopenia—reflecting a shift toward an infection-driven, high-grade systemic inflammatory response—has also been associated with prolonged hospital stay, intensive care admission and death. Our observation that patients in the lowest ENR quartile had a clearly neutrophil-dominant inflammatory profile and a significantly higher risk of in-hospital death is therefore consistent with this pathobiological framework. Importantly, the association remained robust after adjustment for age, sex, lung function, markers of systemic inflammation, indicating that ENR provides prognostic information beyond conventional risk factors. These findings complement those of Chen et al.10, who reported that low peak ENR during the first 2 weeks of intensive care unit treatment, in combination with high C-reactive protein, independently predicted hospital mortality in critically ill acute exacerbation of COPD patients. By demonstrating a similar relationship using a single ENR measurement at admission in a broader hospitalized population, our study extends the utility of ENR as an easily obtainable biomarker for early risk stratification in acute exacerbation of COPD. The lack of association between admission ENR and 12-month mortality in our cohort suggests that ENR is primarily a marker of acute disease severity rather than chronic disease burden. Long-term outcomes in COPD are influenced by multiple factors, including baseline lung function, comorbidities, exacerbation history and treatment adherence, which may dilute the impact of a single inflammatory snapshot captured at admission.131718 Several limitations of this study should be acknowledged. First, this was a retrospective analysis conducted at two affiliated centers within the same regional healthcare system, which may limit the generalizability of the findings to other geographic regions or healthcare settings with different patient characteristics or clinical protocols. Although the inclusion of both a tertiary referral hospital and a secondary care hospital may enhance the representativeness of the study population, external validation in multicenter and diverse populations is warranted to confirm the prognostic utility of ENR. Second, patients who were unable to undergo pulmonary function testing—potentially due to early clinical deterioration or death—were excluded. Third, although acute exacerbation was managed according to GOLD recommendations, patients without acute respiratory failure likely had milder disease severity than those with acute respiratory failure, which may have influenced clinical outcomes. Fourth, ENR was calculated using laboratory values obtained at a single time point on admission, and temporal changes in inflammatory markers during hospitalization were not evaluated. Finally, the number of in-hospital mortality events was relatively small, which may limit the statistical power and warrants cautious interpretation of the results. In conclusion, a low ENR at hospital admission was independently associated with increased in-hospital mortality among patients hospitalized with acute exacerbation of COPD. ENR demonstrated the consistent prognostic value for short-term outcomes but was not associated with long-term survival after discharge, suggesting that it reflects acute disease severity during exacerbation. These findings indicate that ENR may serve as a simple and readily available biomarker for early risk stratification in hospitalized patients with acute exacerbation of COPD.